Site Map

Myelodysplastic Syndromes Topics>

Myelodysplastic Syndromes Home

What Is REVLIMID^®?

RevAssist^®

Important Risk Information

How to Take REVLIMID^®

Understanding Side Effects

Low Blood Counts

Gastrointestinal Disorders

Skin Disorders

Dizziness and Headaches

Other Possible Side Effects

Patient Support Coordinator^®

About MDS

Types of MDS

Causes and Symptoms

Diagnosis and Prognosis

Treatment Options

Drug Therapy

Bone Marrow Transplantation

Transfusions

Lifestyle Modifications

Resources

Patient Medication Guide

Multiple Myeloma Topics

Multiple Myeloma Home

What Is REVLIMID^®?

REVLIMID^® Results

Prescription Process

RevAssist^®

Important Risk Information

How to Take REVLIMID^®

Understanding Side Effects

Blood Clots

Low Blood Counts

Gastrointestinal Disorders

Other Side Effects

Patient Support Coordinator^®

About Multiple Myeloma

Who Gets Multiple Myeloma?

Symptoms of Multiple Myeloma

Multiple Myeloma Glossary

Resources for Patients

Patient Medication Guide

Information for Healthcare Providers

Healthcare Providers Home

REVLIMID^® for Multiple Myeloma

Clinical Trial Design

Efficacy in Multiple Myeloma

WARNINGS and Adverse Events

Dosing and Administration

REVLIMID^® for Myelodysplastic Syndromes

Deletion 5q in MDS

Dosing and Administration

Clinical Trial Design

WARNINGS and Adverse Events

Efficacy: Transfusion Independence

RevAssist^®

RevAssist^® for Prescribers

RevAssist^® for Patients

Patient Support Coordinator^®

	© 2005, Celgene Corporation, www.celgene.com This web site is intended for residents of the United States only. Privacy Policy | Terms of Use